Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
September 30, 2026 4.00M
June 30, 2026 7.772M
March 31, 2026 7.923M
December 31, 2025 1.074M
September 30, 2025 17.88M
June 30, 2025 10.79M
March 31, 2025 14.55M
December 31, 2024 12.23M
September 30, 2024 17.14M
June 30, 2024 18.00M
March 31, 2024 10.20M
December 31, 2023 15.81M
September 30, 2023 12.66M
June 30, 2023 13.58M
Date Value
March 31, 2023 28.99M
December 31, 2022 16.44M
September 30, 2022 1.45M
June 30, 2022 -0.868M
March 31, 2022 40.84M
December 31, 2021 21.03M
September 30, 2021 -16.11M
June 30, 2021 -46.60M
March 31, 2021 -190.52M
December 31, 2020 1.704M
September 30, 2020 -13.10M
June 30, 2020 4.407M
March 31, 2020 -13.61M
December 31, 2019 -0.067M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Caribou Biosciences, Inc. 19.39M
Oncolytics Biotech, Inc. -0.0069M
Sangamo Therapeutics, Inc. -0.013M
Sarepta Therapeutics, Inc. -158.35M
Anixa Biosciences, Inc. -0.245M